Biology Reference
In-Depth Information
32. Sun Y, Xu Y, Roy K, Price BD. DNA damage-induced acetylation of lysine 3016 of ATM
activates ATM kinase activity.
Mol Cell Biol
2007;
:8502-9.
33. Daniel JA, Pellegrini M, Lee JH, Paull TT, Feigenbaum L, Nussenzweig A. Multiple autopho-
sphorylation sites are dispensable for murine ATM activation in vivo.
J Cell Biol
2008;
27
183
:
777-83.
34. Pellegrini M, Celeste A, Difilippantonio S, Guo R, Wang W, Feigenbaum L, et al. Autopho-
sphorylation at serine 1987 is dispensable for murine Atm activation in vivo.
Nature
2006;
443
:
222-5.
35. Eilam R, Peter Y, Elson A, Rotman G, Shiloh Y, Groner Y, et al. Selective loss of dopaminergic
nigro-striatal neurons in brains of Atm-deficient mice.
Proc Natl Acad Sci USA
1998;
:12653-6.
36. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D. Targeted disruption
of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune
defects, and thymic lymphoma.
Genes Dev
1996;
95
:2411-22.
37. Dupre A, Boyer-Chatenet L, Gautier J. Two-step activation of ATM by DNA and the
Mre11-Rad50-Nbs1 complex.
Nat Struct Mol Biol
2006;
10
:451-7.
38. Lee JH, Paull TT. ATM activation by DNA double-strand breaks through the Mre11-
Rad50-Nbs1 complex.
Science
2005;
13
:551-4.
39. Lee JH, Paull TT. Activation and regulation of ATM kinase activity in response to DNA
double-strand breaks.
Oncogene
2007;
308
:7741-8.
40. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. Requirement of the MRN
complex for ATM activation by DNA damage.
EMBO J
2003;
26
:5612-21.
41. Difilippantonio S, Celeste A, Fernandez-Capetillo O, Chen HT, Reina San Martin B, Van
Laethem F, et al. Role of Nbs1 in the activation of the Atm kinase revealed in humanized
mouse models.
Nat Cell Biol
2005;
22
:675-85.
42. Cerosaletti K, Wright J, Concannon P. Active role for nibrin in the kinetics of atm activation.
Mol Cell Biol
2006;
7
:1691-9.
43. Falck J, Coates J, Jackson SP. Conserved modes of recruitment of ATM, ATR and DNA-PKcs
to sites of DNA damage.
Nature
2005;
26
:605-11.
44. Stracker TH, Petrini JHJ. The MRE11 complex: starting from the ends.
Nat Rev Mol Cell Biol
2011;
434
:90-103.
45. Xie A, Kwok A, Scully R. Role of mammalian Mre11 in classical and alternative nonhomolo-
gous end joining.
Nat Struct Mol Biol
2009;
12
:814-8.
46. Taylor AM, Groom A, Byrd PJ. Ataxia-telangiectasia-like disorder (ATLD)—its clinical pre-
sentation and molecular basis.
DNA Repair (Amst)
2004;
16
:1219-25.
47. McKinnon PJ, Caldecott KW. DNA strand break repair and human genetic disease.
Annu Rev
Genomics Hum Genet
2007;
3
:37-55.
48. You Z, Chahwan C, Bailis J, Hunter T, Russell P. ATM activation and its recruitment to
damaged DNA require binding to the C terminus of Nbs1.
Mol Cell Biol
2005;
8
:5363-79.
49. Lee JH, Paull TT. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1
complex.
Science
2004;
25
:93-6.
50. LimDS, Kim ST, Xu B, Maser RS, Lin J, Petrini JH, et al. ATM phosphorylates p95/nbs1 in an
S-phase checkpoint pathway.
Nature
2000;
304
:613-7.
51. Sun Y, Jiang X, Xu Y, Ayrapetov MK, Moreau LA, Whetstine JR, et al. Histone H3 methylation
links DNA damage detection to activation of the tumour suppressor Tip60.
Nat Cell Biol
2009;
404
:1376-82.
52. Kitagawa R, Bakkenist CJ, McKinnon PJ, Kastan MB. Phosphorylation of SMC1 is a critical
downstream event in the ATM-NBS1-BRCA1 pathway.
Genes Dev
2004;
11
:1423-38.
53. Horejsi Z, Falck J, Bakkenist CJ, Kastan MB, Lukas J, Bartek J. Distinct functional domains of
Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing
radiation.
Oncogene
2004;
18
:3122-7.
23
